BackAcceleron Pharma Overview
Acceleron Pharma Inc

Acceleron Pharma Target Price

Acceleron Pharma target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$178.75

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2021-06-24OppenheimerLeland Gershell$16010.5% downsideOpen
2021-06-22Goldman SachsCorinne Jenkins$13922.2% downsideOpen
2021-04-26Credit SuisseTiago Fauth$15115.5% downsideOpen

Acceleron Pharma (XLRN) FAQ

Stockcircle tracks target price for Acceleron Pharma (XLRN), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Acceleron Pharma's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main XLRN overview so you can move from this figure to the surrounding analysis quickly.